CerSci Therapeutics cersci.com


CerSci Therapeutics is poised to deliver a new generation of non-opioid medicines to treat acute postoperative and chronic neuropathic pain (painful diabetic neuropathy). CT-044, CerSci's lead molecular asset, has demonstrated efficacy across a battery of incisional, inflammatory, and neuropathic pain models with a clean animal safety package. CT-044 has completed IND-enablement and has commenced Phase I clinical trial to investigate safety and tolerability in healthy normal volunteers.

CerSci Therapeutics is poised to deliver a new generation of non-opioid medicines to treat acute postoperative and chronic neuropathic pain (painful diabetic neuropathy). CT-044, CerSci's lead molecular asset, has demonstrated efficacy across a batte...Show all

Company (Alive / Active)

Phone:

Fax:

17217 Waterview Parkway
Suite 1.202
Dallas, 75252
Texas, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
CerSci Therapeutics $10.2M Oct 8, 2019

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related CerSci Therapeutics Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 4 investors
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)